RBCL (RBC Life Sciences) Cyclically Adjusted FCF per Share: $0.00 (As of Jun. 2017)


What is RBC Life Sciences Cyclically Adjusted FCF per Share?

RBC Life Sciences RBCL +0.14% Cyclically Adjusted FCF per Share is $0.00 as of Jun. 2017.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

RBC Life Sciences's adjusted free cash flow per share for the three months ended in Jun. 2017 was $0.083. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Jun. 2017.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-07), RBC Life Sciences's current stock price is $0.0007. RBC Life Sciences's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2017 was $0.00. RBC Life Sciences's Cyclically Adjusted Price-to-FCF of today is .


RBC Life Sciences  (OTCPK:RBCL) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


RBC Life Sciences Cyclically Adjusted FCF per Share Related Terms


RBC Life Sciences Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Cyclically Adjusted FCF per Share Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RBCL vs SKVI, TISUQ, TECR: Cyclically Adjusted FCF per Share Comparison

For the Household & Personal Products subindustry, RBC Life Sciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RBC Life Sciences Cyclically Adjusted Price-to-FCF vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where RBC Life Sciences's Cyclically Adjusted Price-to-FCF falls into.



RBC Life Sciences Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RBC Life Sciences's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2017 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2017 (Change)*Current CPI (Jun. 2017)
=0.083/244.9550*244.9550
=0.083

Current CPI (Jun. 2017) = 244.9550.

RBC Life Sciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200709 0.737 208.490 0.866
200712 0.499 210.036 0.582
200803 -0.293 213.528 -0.336
200806 -0.141 218.815 -0.158
200809 0.735 218.783 0.823
200812 -0.956 210.228 -1.114
200903 0.222 212.709 0.256
200906 -0.652 215.693 -0.740
200909 -0.230 215.969 -0.261
200912 0.231 215.949 0.262
201003 -0.176 217.631 -0.198
201006 0.079 217.965 0.089
201009 0.525 218.439 0.589
201012 -0.258 219.179 -0.288
201103 0.573 223.467 0.628
201106 0.091 225.722 0.099
201109 -0.419 226.889 -0.452
201112 -0.356 225.672 -0.386
201203 -0.540 229.392 -0.577
201206 -0.010 229.478 -0.011
201209 -0.074 231.407 -0.078
201212 0.462 229.601 0.493
201303 -0.246 232.773 -0.259
201306 -0.094 233.504 -0.099
201309 0.600 234.149 0.628
201312 -0.127 233.049 -0.133
201403 -0.786 236.293 -0.815
201406 0.107 238.343 0.110
201409 -0.319 238.031 -0.328
201412 0.237 234.812 0.247
201503 -0.407 236.119 -0.422
201506 0.012 238.638 0.012
201509 -1.309 237.945 -1.348
201512 -0.299 236.525 -0.310
201603 -0.258 238.132 -0.265
201606 -0.004 241.018 -0.004
201609 0.251 241.428 0.255
201612 0.014 241.432 0.014
201703 -0.267 243.801 -0.268
201706 0.083 244.955 0.083

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.00 mean?
RBC Life Sciences (RBCL) has a Cyclically Adjusted FCF per Share of $0.00 as of Jun. 2017. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Cyclically Adjusted FCF per Share too high?
RBC Life Sciences' current Cyclically Adjusted FCF per Share is $0.00.
How does RBC Life Sciences' Cyclically Adjusted FCF per Share compare to SKVI and TISUQ?
RBC Life Sciences' Cyclically Adjusted FCF per Share of $0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted FCF per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on RBC Life Sciences and its competitors. RBC Life Sciences's current Cyclically Adjusted FCF per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Cyclically Adjusted FCF per Share of $0.00. The current Cyclically Adjusted FCF per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Cyclically Adjusted FCF per Share is $0.00 as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.